HighRisk

A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to…

First and only subcutaneous anti-CD38 therapy demonstrating potential to prevent end-organ damage, and extend progression-free survival and overall survival based…

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have discovered a significant association between…

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and long-term management of…

September marks National Food Safety Education Month, and the Food and Drug Administration is urging Americans to focus on food…

CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear…